GLIOBLASTOMA MULTIFORME, ADULT
Clinical trials for GLIOBLASTOMA MULTIFORME, ADULT explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME, ADULT trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene armor for bone marrow lets doctors hit brain tumors harder
Disease control Recruiting nowThis trial is testing a two-part treatment for an aggressive type of brain cancer called glioblastoma. First, doctors collect a patient's own blood stem cells and modify them with a protective gene. Then, they give the cells back to the patient so their bone marrow can withstand …
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Leland Metheny • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Sharper radiation aimed at deadly brain cancer
Disease control Recruiting nowThis study is testing a refined radiation technique for adults with glioblastoma, a very aggressive brain cancer. It aims to see if using a special PET scan to guide a higher, more focused dose of radiation to the most active tumor areas can help patients live longer. The trial i…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope in fight against aggressive brain cancer
Disease control Recruiting nowThis study is testing whether adding an investigational drug called ruxolitinib to the standard treatment (radiation and chemotherapy) helps people with newly diagnosed glioblastoma live longer. About 190 adults will be randomly assigned to receive either the standard treatment a…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New radiation 'Smart Bomb' targets deadly brain cancer in global trial
Disease control Recruiting nowThis global Phase 3 trial is testing whether adding a new targeted radiation therapy (TLX101-Tx) to standard chemotherapy (lomustine) works better than chemotherapy alone for adults whose aggressive brain cancer (glioblastoma) has returned for the first time. The new therapy aims…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC